US Drug Recall Register
Class II · Moderate risk Terminated Initiated Mar 9, 2015 (11 years ago)

Fomepizole Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility. A recent FDA inspection reported GMP violations potentially impacting product quality and sterility.

What was recalled

Fomepizole Injection, 1.5 g/1.5 mL (1 g/mL), For Intravenous Infusion only, Rx only, Manufactured by: Emcure Pharmaceuticals Lt. for Sandoz Inc., Princeton, NJ 08540, NDC 0781-3182-73 and 0781-3182-84

Recalling firm
Navinta LLC
NDC code
0781-3182-73
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0431-2015

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.